MEDIA RELEASE - OMediHerb awarded 2015 ABC Varro E.Tyler Award

MediHerb awarded 2015 ABC Varro E. Tyler Commercial Investment in Phytomedical Research Award

Australian company wins top gong for ongoing commitment to
natural therapy research

Leading Australian natural therapies brand MediHerb, an Integria Healthcare brand, has been awarded the 2015 ABC Varro E. Tyler Commercial Investment in Phytomedical Research Award by The American Botanical Council (ABC). The 11th Annual ABC Botanical Celebration and Awards Ceremony took place yesterday in Anaheim California where Professor Kerry Bone (MediHerb) and Dr Hans Wohlmuth (Integria Healthcare) accepted the award via video message.

The prestigious international award recognises companies with the highest level of scientific and product integrity who are dedicated to extensive evaluation of their products' quality, safety and efficacy in the phytomedicinal healthcare sector.

MediHerb and Integria Healthcare have supported around 25 human clinical trials of MediHerb products, 22 of which have been published in peer-reviewed journals. In addition to clinical trials, MediHerb has funded a large number of phytochemistry and in vitro studies on botanicals. Much of this work has focused on quality issues, an area in which MediHerb has always been a leader.

Professor Kerry Bone, MediHerb’s Director of Research and Development and visionary behind the company’s research program, was thrilled to be recognised for MediHerb’s dedication to more than 15 years of conducting clinical research.

“This is a greatly appreciated reward for our many years of research into the phytochemistry, quality and therapeutic properties of medicinal plants. The ABC is to be commended on the way it supports the development and status of the global herbal industry through such awards.”

“There is now a compelling argument for new drug research to be looking at developing and using the whole plant as the therapeutic agent, rather than just an isolated chemical from it. Previously such an approach was frowned on because of the variability and uncertainty created by the chemical complexity of plants. Now we have such advances in phytochemical analysis and pharmacodynamics that these obstacles are readily overcome. It is indeed an exciting time to be doing phytomedicinal research.”

Dr Hans Wohlmuth, Research and Development Manager for Integria Healthcare said the award was a testament to the company’s commitment to leading the market in safety, quality and efficacy.

“From the outset 30 years ago, MediHerb has embodied Professor Tyler’s vision of applying science to traditional botanical medicine with the sole aim of providing practitioners with high quality and clinically efficacious products. We are thrilled to be recognised for our work,” said Dr Wohlmuth.

Integria Healthcare, which owns the MediHerb brand along with other leading natural healthcare brands, invests more than $5 million annually in research and development and technical projects.

View the full acceptance speech from the awards ceremony HERE